INTEGRA LIFESCIENCES HOLDINGS CORP Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-02-21
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-09-30 was 158.00K shares, a 92.15% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2019 was 0.00 shares.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2018 was 0.00 shares, a 100.00% decline from fiscal 2017.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 971.00K shares, a 16.72% decline from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 1.17M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | 0.00 shares 10-K · filed 2020-02-21 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2020-02-21 | |||
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-01 | 0.00 shares 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-07-26 | 0.00 shares 10-Q · filed 2018-07-26 | ||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-04-26 | |||
| 2017-12-31 | 971.00K shares 10-K · filed 2020-02-21 | |||
| 2017-09-30 | 158.00K shares 10-Q · filed 2018-11-01 | 1.29M shares 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | 1.59M shares 10-Q · filed 2018-07-26 | 1.86M shares 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | 2.14M shares 10-Q · filed 2018-04-26 | |||
| 2016-12-31 | 1.17M shares 10-K · filed 2019-02-26 | |||
| 2016-09-30 | 2.01M shares 10-Q · filed 2017-10-26 | 974.00K shares 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | 911.00K shares 10-Q · filed 2017-07-26 | 454.00K shares 10-Q · filed 2017-07-26 | ||
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-04-26 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |